Hepatotoxicity induced by antifungal drugs itraconazole and fluconazole in rats: a comparative in vivo study

Abstract

Itraconazole and fluconazole are oral antifungal drugs, which have a wide spectrum antifungal activity and better efficacy than the older drugs. However, both drugs have been associated with hepatotoxicity in susceptible patients. The mechanism of antifungal drug-induced hepatotoxicity is largely unknown. Therefore, the aim of this present study was to investigate and compare the hepatotoxicity induced by these drugs in vivo. Rats were treated intraperitoneally with itraconazole or fluconazole either single (0, 10, l00 and 200 mg/kg) or subchronic (0, 10, 50 and loo mg/kg per day for 14 days) doses. Plasma and liver samples were taken at the end of the study. A statistically significant and dose dependent increase of plasma alanine aminotransferase (ALT) and alkaline phosphatase (ALP) activities were detected in the subchronic itraconazole-treated group. In addition, dose-dependent hepatocellular necrosis, degeneration of periacinar and mizonal hepatocytes, bile duct hyperplasia and biliary cirrhosis and giant cell granuloma were observed histologically in the same group. Interestingly, fluconazole treated rats had no significant increase in transaminases for both single and subchronic groups. In the subchronic fluconazole treated rats, only mild degenerative changes of centrilobular hepatocytes were observed. These results demonstrated that itraconazole was a more potent hepatotoxicant than fluconazole in vivo in rats.

Keywords

fluconazole hepatotoxicity itraconazole rats

References

1 Terrell CL . Antifungal agents. Part II. The azoles . Mayo Clin Proc 1999; 74(1): 78-100 .

2 Zuckerman JM , Tunkel AR . Itraconazole: a new triazole antifungal agent . Infec Control Hosp Epidemiol 1994; 15: 397-410 .

3 Bailey EM , Krakovsky DJ , Rybak MJ . The triazole antifungal agent: a review of itraconazole and fluconazole . Pharmacol Therapy 1990; 10: 146-153 .

4 Haria M , Bryson HM , Goa KL . Itraconazole: A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infection . Drugs 1996; 51: 586-620 .

5 Saag MS , Dismukes, WE . Azole antifungal agents: emphasis on new triazoles . Antimicro Agents Chem 1988; 32: 1-8 .

6 Inman W , Kubota K , Pearce G . PEM report No. 7. Itraconazole . Pharmacoepidimiol Drug Safety 1993; 2: 424-443 .

7 Restrepo A , Roobledo J , Gomez I . Itraconazole therapy in lymphagenic and cutaneous sporotrichosis . Arch Dermatol 1986; 122: 413-417 .

8 Lavrijsen APM , Balmus KJ , Nugteren-Huying WM , Roldaan AC , Vant Wout JW , Stricker BHC . Hepatic injury associated with itraconazole . Lancet 1992; 340: 251-252 .

9 Lavrijsen AP , Balmus KJ , Nugteren-Huying WM , Roldaan AC , van't Wout JW , Stricker BH . Liver damage during administration of itraconazole . Ned Tijdschr Geneeskd 1993; 137: 38-41 .

10.

10 Tucker RM , Haq Y , Denning DW , Stevens DA . Adverse events associated with itraconazole in 189 patients on chronic therapy . J Antimicrob Chemother 1990; 26: 561-566 .

11.

11 Hecht FM , Wheat J , Korzun AH , Hafner R , Skahan KJ , Larsen R , Limjoco MT , Simpson M , Schneider D , Keefer MC , Clark R , Lai KK , Jacobson JM , Squires K , Bartlett JA , Powderly W . Itraconazole maintenance treatment for histoplasmosis in AIDS: a prospective, multicenter trial . J AIDS 1997; 16(2): 100-107 .

12.

12 Grant SM , Clissold SP . Fluconazole. A review of its pharmacodynamics and pharmacokinetics properties and therapeutic potential in superficial and systemic mycoses . Drugs 1990; 39: 877-916 .

13.

13 van der Horst CM . Saag MS . Cloud GA . Hamill RJ . Graybill JR . Sobel JD . Johnson PC . Tuazon CU . Kerkering T . Moskovitz BL . Powderly WG . Dismukes WE . Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome . New Engl J Med 1997; 337(1): 15-21 .

14.

14 Jacobson MA , Hanks DK , Ferrell LD . Fatal acute hepatic necrosis due to fluconazole . Am J Med 1994; 96(2): 188-190 .

15.

15 Somchit N , Hassim SM , Samsudin SH . Itraconazoleand fluconazole-induced toxicity in rat hepatocytes: a comparative in vitro study . Hum Exp Toxicol 2002; 21(1): 43-48 .

16.

16 Pekarthy J , Albert JS , Lansing A , Lieberman I . Function and control of liver alkaline phosphatase . J Biol Chem 1972; 247: 1767-1774 .

17.

17 Van Cutsem J , Van Gerven F , Van de Ven MA , Borgers M , Janssen, PAJ . Itraconazole, a new triazole that is orally active in aspergillosis . Antimicrob Agents Chemother 1984; 26(4): 527-534 .

18.

18 Rodriquez RJ , Acosta D Jr . Inhibition of mitochondrial function in isolated rate liver mitochondria by azole antifungals . J Biochem Toxicol 1996; 11: 127-131 .

19.

19 Rodriquez RJ , Acosta D Jr . N-Deacetyl ketoconazoleinduced hepatotoxicity in a primary culture system of rat hepatocytes . Toxicology 1997; 117: 123-131 .

20.

20 Rodriquez RJ , Acosta D Jr . Metabolism of ketoconazole and deacetylated ketoconazole by rat hepatic microsomes and flavin-containing monooxygenase . Dru. Metab. Dispos 1997; 25: 727-777 .

21.

21 Rodriquez RJ , Proteau PJ , Marquez BL , Hetherington CL , Acosta D Jr . Flavin-ontaining monooxygenasemediated metabolism of N-deacetyl ketoconazole by rat hepatic microsomes . Drug Metab Dispos 1999; 27: 880-886 .

22.

22 Martin MV . The use of fluconazole and itraconazole in the treatment of Candida albicans infections: a review . J Antimicrob Chemother 1999; 44(4): 429-437 .

23.

23 Menon T , Umamaheswari K , Kumarasamy N , Solomon S , Thyagarajah SP . Efficacy of fluconazole and itraconazole in the treatment of oral candidiasis in HIV patients . Acta Trop 2001; 80: 151-154 .

24.

24 Chotmongkol V , Sukeepaisarncharoen W . Maintenance therapy with itraconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome . J Med Assoc Thai 1997; 80(12): 767-770

25.

25 Hecht FM , Wheat J , Korzun AH , Hafner R , Skahan KJ , Larsen R , Limjoco MT , Simpson M , Schneider D , Keefer MC , Clark R , Lai KK , Jacobson JM , Squires K , Bartlett JA , Powderly W . Itraconazole maintenance treatment for histoplasmosis in AIDS: a prospective, multicenter trial . J AIDS Hum Retrovirol 1997; 16(2): 100-107 .